(ACAD) Acadia Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Acadia Pharmaceuticals | (ACAD) share price targets
Complete technical analysis of Acadia Pharmaceuticals (ACAD) by charts plus indicators, forecast predictions and share price targets for Acadia Pharmaceuticals (ACAD)
Acadia Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-06 View latest technical analysis
10 day averaged volume of Acadia Pharmaceuticals is 1342600
| Date | Daily Closing Price | Open | High | Low | Volume |
| 06 Fri Sep 2024 | 16.07 | 16.32 | 16.46 | 15.76 | 0.638 times |
| 05 Thu Sep 2024 | 16.22 | 16.09 | 16.77 | 16.05 | 0.862 times |
| 04 Wed Sep 2024 | 16.69 | 16.42 | 16.85 | 16.19 | 1.011 times |
| 03 Tue Sep 2024 | 16.36 | 16.56 | 17.03 | 16.35 | 0.945 times |
| 30 Fri Aug 2024 | 16.58 | 16.44 | 16.63 | 16.27 | 0.676 times |
| 30 Fri Aug 2024 | 16.58 | 16.44 | 16.63 | 16.27 | 0.676 times |
| 29 Thu Aug 2024 | 16.32 | 15.87 | 16.44 | 15.71 | 0.793 times |
| 28 Wed Aug 2024 | 15.70 | 15.77 | 15.94 | 15.57 | 0.842 times |
| 27 Tue Aug 2024 | 15.75 | 16.06 | 16.14 | 15.49 | 0.787 times |
| 26 Mon Aug 2024 | 16.09 | 16.08 | 16.33 | 15.89 | 1.515 times |
My analysis of stock is bullish for shortterm, and stock might move up till 16.3 or till 16.9. Use a stoploss of 15.91 and if this stock hits its stoploss, then it can fall down till 15.47
Share price targets for Acadia Pharmaceuticals (ACAD)
| Target Type | Value |
| Downside Target | 14.55 |
| Downside Target | 15.08 |
| Upside Target | 16.27 |
| Upside Target | 16.53 |
| Upside Target | 16.63 |
| Upside Target | 17.03 |
| Upside Target | 17.58 |
| Upside Target | 19.42 |
| Upside Target | 19.44 |
Intraday share price targets for Acadia Pharmaceuticals (ACAD)
| Target Type | Value |
| Downside Intraday Target | 15.54 |
| Downside Intraday Target | 15.02 |
| Upside Intraday Target | 16.81 |
| Upside Intraday Target | 17.56 |
| Upside Intraday Target | 16.29 |
Weekly technical analysis of Acadia Pharmaceuticals (ACAD)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 06 Fri Sep 2024 | 16.07 | 16.56 | 17.03 | 15.76 | 5.113 times |
| 30 Fri Aug 2024 | 16.58 | 16.44 | 16.63 | 16.27 | 0.147 times |
| 30 Fri Aug 2024 | 16.58 | 16.08 | 16.63 | 15.49 | 0.768 times |
| 23 Fri Aug 2024 | 15.94 | 15.28 | 16.04 | 15.28 | 1.087 times |
| 16 Fri Aug 2024 | 15.40 | 15.59 | 16.00 | 15.13 | 0.399 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Acadia Pharmaceuticals (ACAD)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 06 Fri Sep 2024 | 16.07 | 16.56 | 17.03 | 15.76 | 0.103 times |
| 30 Fri Aug 2024 | 16.58 | 19.08 | 19.42 | 15.08 | 1.14 times |
| 31 Wed Jul 2024 | 19.02 | 16.19 | 19.44 | 15.40 | 1.2 times |
| 28 Fri Jun 2024 | 16.25 | 15.12 | 16.53 | 14.55 | 0.814 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Acadia Pharmaceuticals (ACAD)
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Acadia Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Acadia Pharmaceuticals in short term but the buy signal is initial and weak.
Acadia Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Acadia Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Acadia Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 16.23 and Acadia Pharmaceuticals (ACAD) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Acadia Pharmaceuticals (ACAD) stock. Volume based technical analysis of Acadia Pharmaceuticals (ACAD) stock is negative.
Acadia Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Acadia Pharmaceuticals ( (ACAD) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Acadia Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Acadia Pharmaceuticals in short term but the buy signal is initial and weak.
Acadia Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Acadia Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Acadia Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 16.23 and Acadia Pharmaceuticals (ACAD) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Acadia Pharmaceuticals (ACAD) stock. Volume based technical analysis of Acadia Pharmaceuticals (ACAD) stock is negative.
Acadia Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.